COVID Spreads To 60 Plants, Sparks Fear Of US Food Shortages As 2nd Wave Strikes

Follow us on social media

A new report reveals the severity of #COVID19 spreading beyond meatpacking plants to food processing facilities across the US.


The Environmental Working Group (EWG) outlines this new reality of how the fast-spreading virus has infected 1,200 food processing workers at 60 plants from mid-March to early June.


To compile these statics, EWG reviewed news articles of outbreaks and noticed many of the infections were seen at #KraftHeinz, #BirdsEye, #Conagra, and the #CampbellSoup Company’s #PepperidgeFarm, as well as those of smaller plants, like #FairmontFoods and #RuizFoods.

Food Processing Plants With the Most Reported COVID-19 Cases

Bloomberg elaborated on EWG’s findings and said: “These are the first national numbers of their kind. The advocacy group compiled its figures using local media reports because there are no federal agencies reporting the data. The true total is almost certainly higher.” Bakers, dairy workers, fruit and vegetable packers, many of whom are deemed “essential” have worked through the pandemic, sometimes laboring in tight quarters. “At our workplace, we were not ready for this virus. We didn’t talk about it. We didn’t know about it,” Paula Zambrano,61, who packs fruit at Borton & Sons in Yakima, #Washington. She was so concerned back in April of an outbreak at her plant that she stayed home for three weeks. Low on money, she returned to work to support her family. “People are infected, and they come to work. They keep quiet about it,” Zambrano said.

“We live from our work. We are surviving from our wages. If we have children, how will we feed them?” In a piece titled “”Cold, Damp & Crowded” – How America’s Meat Plants Are Breeding Grounds For Covid” — we described how meat processing plants had become a breeding ground for the virus — and with EWG’s report this week, similar conditions have been seen across many other types of food processing plants.


EWG estimates at least 1.8 million Americans work in food processing plants. Many of the workers are low-income and minority, their labor in tight workspaces make them susceptible to infection.

America’s food suppliers have seen some of the worst outbreaks of the virus. Dozens of folks at meatpacking plants across the country have died with thousands infected. The ongoing human tragedy at meat and food processing plants expose the vulnerability of the food supply chain.


To solve this issue, we noted how meat processing plants should “unleash a new wave of automation across plants to ease labor and health woes.” With a health crisis still not abating at many plants — another problem has developed, that is, food shortages and skyrocketing food inflation.
The latest food at home index increased 4.8% over the last 12 months, with all six major grocery store food group indexes rising over that span.

The index for meats, poultry, fish, and eggs rose 10% over the last year, its most significant 12-month increase since the period ending May 2004.

A second coronavirus wave could spell disaster for America’s food supply chain. At the moment, the stock market is selling off, with investors nervous that a reemergence of the virus is ahead.

Related Articles

COVID Reference

Six weeks after the third edition, the world has changed again.
The pandemic is raging in South America, particularly in Brazil,
Ecuador and Peru. SARS-CoV-2 is under control in China, but in
Iran it is not. And in Europe, where most countries have weathered
the first wave and open borders to save a compromised tourist season, is now wondering if and for how long this biological
drôle de guerre could last.

Science has moved ahead, too. We have seen a more complex
picture of COVID-19 and new clinical syndromes; the first data
from vaccine trials; first results from randomized controlled
drug studies; encouraging publications on monoclonal neutralizing antibodies and serological evidence about the number of people who have come into contact with SARS-CoV-2. Unfortunately, we have also seen the first science scandal with fake data published in highly ranked journals. And we face new challenges like long-term effects of COVID-19 and a Kawasaki-like inflammatory multisystem syndrome in children.

For quite some time, prevention will continue to be the primary
pillar of pandemic control. In future waves of the SARS-CoV-2
pandemic, we will focus on the conditions under which SARSCoV-
2 is best transmitted: crowded, closed (and noisy) places and
spaces. Although hospitals are not noisy, they are crowded and
closed, and the battle against the new coronavirus will be decided
at the very center of our healthcare system. Over the next
months and maybe years, one of all of our top priorities will be
to give all healthcare workers and patients perfect personal protective equipment.

Deleterious Effects of Vaccines – 100s of resources

How can evidence be ignored? http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878266/ http://www.ncbi.nlm.nih.gov/pubmed/21623535 http://www.ncbi.nlm.nih.gov/pubmed/25377033 http://www.ncbi.nlm.nih.gov/pubmed/24995277 http://www.ncbi.nlm.nih.gov/pubmed/12145534 http://www.ncbi.nlm.nih.gov/pubmed/21058170 http://www.ncbi.nlm.nih.gov/pubmed/22099159 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364648/ http://www.ncbi.nlm.nih.gov/pubmed/17454560 http://www.ncbi.nlm.nih.gov/pubmed/19106436 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774468/ http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697751/ http://www.ncbi.nlm.nih.gov/pubmed/21299355 http://www.ncbi.nlm.nih.gov/pubmed/21907498 http://www.ncbi.nlm.nih.gov/pubmed/11339848 http://www.ncbi.nlm.nih.gov/pubmed/17674242 http://www.ncbi.nlm.nih.gov/pubmed/21993250 http://www.ncbi.nlm.nih.gov/pubmed/15780490 http://www.ncbi.nlm.nih.gov/pubmed/12933322 http://www.ncbi.nlm.nih.gov/pubmed/16870260…

The HPV Vaccine: An Ethical Dilemma

In 2014 there were numerous reports of mass hysteria and mystery illnesses spreading around the small town of El Carmen De Bolivar, Colombia. According to an article published by CBS, there was a steady increase of young women being hospitalized in this small town, all of which reported the same symptoms of fainting, numbness and tingling of the hands and feet, and headaches. Speculations about the Gardasil vaccination arose, but were disregarded by the mayor of the town stating that “there is no evidence the vaccine, which has undergone extensive testing and regulation is to blame” (CBS, 2014). According to this statement, he is not necessarily wrong, because the clinical trials of this vaccine have been proven to have misleading conclusions due to errors in the study design.

New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?

Recently, a novel coronavirus (2019-nCoV), officially known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China. Despite drastic containment measures, the spread of this virus is ongoing. SARS-CoV-2 is the aetiological agent of coronavirus disease 2019 (COVID-19) characterised by pulmonary infection in humans. The efforts of international health authorities have since focused on rapid diagnosis and isolation of patients as well as the search for therapies able to counter the most severe effects of the disease. In the absence of a known efficient therapy and because of the situation of a public health emergency, it made sense to investigate the possible effect of chloroquine/hydroxychloroquine against SARS-CoV-2 since this molecule was previously described as a potent inhibitor of most coronaviruses, including SARS-CoV-1. Preliminary trials of chloroquine repurposing in the treatment of COVID- 19 in China have been encouraging, leading to several new trials. Here we discuss the possible mechanisms of chloroquine interference with the SARS-CoV-2 replication cycle.

Responses